News | Archive Cloud Storage | December 01, 2025

Atlas 2 is a major upgrade to Gradient’s self-service medical imaging data platform, giving AI developers a faster, more streamlined way to build representative datasets. The upgrade will be demonstrated at RSNA 2025.


Nov. 30, 2025 — Gradient Health, Inc. has released Atlas 2, a major upgrade to its self-service medical imaging data platform used by AI developers worldwide. The new version introduces deeper search capabilities, a redesigned developer experience and improved collaboration tools to streamline the process of building representative imaging datasets.

Atlas 2 provides immediate access to more than 20 million imaging studies, with a further 30 million in progress or contracting. The platform now supports hundreds of DICOM tags, rich series-level metadata and longitudinal patient-level search, giving developers a level of visibility and precision that previously required significant manual effort or custom pipelines.

Searchability: Atlas 2 expands the depth of search with more metadata, more structure and more context. Developers can filter across hundreds of DICOM tags, explore series-level information and review patient-level histories. These capabilities make it easier to define cohorts that reflect real clinical scenarios and avoid blind spots that can limit model performance.

Usability: Atlas 2 introduces a faster and more intuitive interface designed to reduce friction at every stage of dataset creation. Navigation is simpler, cohort building is quicker and the overall workflow allows users to move from search to export with fewer steps. The platform is built for developers who need rapid access to imaging data at scale without compromising on quality.

Collaboration: Teams can now work together more effectively with shared cohorts, common workspaces and improved dataset analytics. Atlas 2 supports visibility across projects and allows groups to review, refine and manage datasets in a consistent way. This helps organizations maintain quality and accelerate development across multiple projects.

“The future of medical AI will be driven by developers who can access high quality imaging data quickly and responsibly, whether they are training targeted clinical tools or building large foundation models” said Josh Miller, CEO of Gradient, “Atlas 2 gives them that foundation. We designed it to remove friction, improve clarity, and support progress that improves outcomes for entire populations, not just those who are already well served.”

Atlas 2 is available immediately. Gradient will feature daily sessions throughout RSNA 2025 for attendees who want a guided look at the new capabilities. Developers not in Chicago can get started today with a free 7 day trial.

To explore Atlas 2, book a meeting at RSNA, view the daily demo schedule, or start a free trial, visit: gradienthealth.io/rsna

Additional information is available at GradientHealth.io


Related Content

News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | RSNA

The Nominating Committee for the Radiological Society for North America (RSNA) is seeking nominations for qualified ...

Time February 12, 2026
arrow
News | Radiology Business

Feb. 3, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...

Time February 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
News | Computed Tomography (CT)

Feb. 4, 2026 — A new review published in the American Journal of Roentgenology (AJR) finds that advances in CT ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Interventional Radiology

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 02, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Computed Tomography (CT)

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...

Time January 23, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
Subscribe Now